Patient-reported Outcomes with Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% Maintenance Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Antibodies to Ha, Ks, and Zo: Frequency and Characteristics of Antibody-positive Patients in an Unselected Cohort